Laffer Tengler Investments’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.6M Buy
49,706
+909
+2% +$212K 1.62% 19
2026
Q1
$11.9M Buy
48,797
+2,523
+5% +$588K 1.76% 14
2025
Q4
$9.58M Buy
46,274
+2,874
+7% +$568K 1.46% 17
2025
Q3
$8.05M Sell
43,400
-7,015
-14% -$1.2M 1.27% 25
2025
Q2
$7.7M Sell
50,415
-7,626
-13% -$1.17M 1.37% 22
2025
Q1
$9.63M Buy
58,041
+3,728
+7% +$583K 2.05% 12
2024
Q4
$7.85M Sell
54,313
-6,339
-10% -$982K 1.54% 21
2024
Q3
$9.83M Buy
60,652
+1,104
+2% +$176K 1.99% 13
2024
Q2
$8.7M Buy
59,548
+10,126
+20% +$1.51M 1.88% 13
2024
Q1
$7.82M Sell
49,422
-136
-0.3% -$21.6K 2.02% 12
2023
Q4
$7.77M Buy
49,558
+2,087
+4% +$320K 2.06% 8
2023
Q3
$7.39M Buy
47,471
+5,704
+14% +$941K 2.17% 5
2023
Q2
$6.91M Buy
41,767
+4,213
+11% +$680K 1.83% 4
2023
Q1
$5.82M Sell
37,554
-351
-0.9% -$56.7K 1.58% 10
2022
Q4
$6.7M Buy
37,905
+7,899
+26% +$1.36M 1.93% 4
2022
Q3
$4.9M Buy
30,006
+1,075
+4% +$182K 1.8% 4
2022
Q2
$5.14M Sell
28,931
-1,057
-4% -$188K 1.8% 4
2022
Q1
$5.31M Sell
29,988
-870
-3% -$148K 1.6% 6
2021
Q4
$5.28M Buy
30,858
+1,527
+5% +$250K 1.52% 7
2021
Q3
$4.74M Buy
29,331
+6,215
+27% +$1.06M 1.37% 5
2021
Q2
$3.81M Sell
23,116
-1,787
-7% -$296K 1.43% 11
2021
Q1
$4.09M Buy
24,903
+2,923
+13% +$473K 1.55% 9
2020
Q4
$3.43M Buy
21,980
+1,746
+9% +$258K 1.45% 14
2020
Q3
$3.01M Buy
20,234
+1,111
+6% +$164K 1.51% 13
2020
Q2
$2.69M Buy
19,123
+3,708
+24% +$540K 1.55% 18
2020
Q1
$2.02M Buy
15,415
+1,495
+11% +$212K 1.58% 22
2019
Q4
$2.03M Buy
13,920
+9,165
+193% +$1.24M 1.35% 28
2019
Q3
$615K Sell
4,755
-2
-0% -$263 0.53% 57
2019
Q2
$663K Buy
4,757
+152
+3% +$21K 0.57% 53
2019
Q1
$644K Sell
4,605
-562
-11% -$75.3K 0.17% 146
2018
Q4
$667K Sell
5,167
-67
-1% -$9.35K 0.2% 139
2018
Q3
$723K Sell
5,234
-267
-5% -$35.5K 0.18% 146
2018
Q2
$667K Sell
5,501
-115
-2% -$14.3K 0.17% 154
2018
Q1
$720K Buy
5,616
+38
+0.7% +$5.14K 0.18% 145
2017
Q4
$779K Sell
5,578
-508
-8% -$70.8K 0.2% 158
2017
Q3
$791K Sell
6,086
-274
-4% -$36.3K 0.21% 155
2017
Q2
$841K Sell
6,360
-22
-0.3% -$2.81K 0.21% 159
2017
Q1
$795K Sell
6,382
-2,122
-25% -$253K 0.21% 163
2016
Q4
$980K Sell
8,504
-47,202
-85% -$5.45M 0.26% 163
2016
Q3
$6.58M Buy
55,706
+398
+0.7% +$48.3K 1.83% 3
2016
Q2
$6.71M Buy
55,308
+48,862
+758% +$5.55M 1.91% 3
2016
Q1
$697K Buy
+6,446
New +$667K 0.19% 165
2015
Q4
Hold
0
170
2015
Q3
Sell
-19,316
Closed -$1.87M 146
2015
Q2
$1.88M Sell
19,316
-107,543
-85% -$10.8M 0.46% 78
2015
Q1
$12.8M Buy
+126,859
New +$12.9M 1.79% 16
2014
Q4
Sell
-116,193
Closed -$12.2M 13
2014
Q3
$12.4M Buy
116,193
+14,209
+14% +$1.47M 1.83% 9
2014
Q2
$10.7M Buy
101,984
+8,051
+9% +$814K 1.64% 14
2014
Q1
$9.23M Sell
93,933
-7
-0% -$649 1.48% 13
2013
Q4
$8.6M Buy
+93,940
New +$8.66M 1.42% 17
2013
Q3
Sell
-109,784
Closed -$9.85M 3
2013
Q2
$9.43M Buy
+109,784
New +$9.32M 1.85% 3

Other funds holding JNJ

Laffer Tengler Investments's JNJ Position: Q2 2026 in Review

Laffer Tengler Investments increased its Johnson & Johnson (JNJ) stake by 1.9% in Q2 2026, buying an estimated $212K and bringing the position to 49,706 shares worth $12.6M. The position accounts for 1.62% of the portfolio, ranked #19.

Laffer Tengler Investments first reported a position in JNJ in Q2 2013 and has held it in 49 quarters since. The position peaked at $12.8M in Q1 2015. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Laffer Tengler Investments held 49,706 shares of Johnson & Johnson worth $12.6M as of Q2 2026.
  • Laffer Tengler Investments bought 909 Johnson & Johnson shares in Q2 2026, an estimated $212K.
  • Johnson & Johnson made up 1.62% of Laffer Tengler Investments's portfolio in Q2 2026, its #19 holding.
  • Laffer Tengler Investments first reported a position in Johnson & Johnson in Q2 2013 and has held it in 49 quarters since.
  • Laffer Tengler Investments's Johnson & Johnson position peaked at $12.8M in Q1 2015.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Laffer Tengler Investments's 13F filing for Q2 2026, filed 21 Jul 2026.